Synergistic effects of prenatal hypoxia and postnatal high-fat diet in the development of cardiovascular pathology in young rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 4, 2012, Pages

  Rueda Clausen, Christian F ^a   Morton, Jude S ^a   Dolinsky, Vernon W ^a   Dyck, Jason R B ^a   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Growth restriction; Ischemia reperfusion; Programming; Resveratrol; Ultrasound; Vascular function; Western diet

Indexed keywords

RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH WEIGHT; BLOOD VESSEL COMPLIANCE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; EX VIVO STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HEART CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART PROTECTION; HEART RATE; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART STROKE VOLUME; HEART VENTRICLE EJECTION TIME; HYPOXIA; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; LIPID DIET; MALE; NEWBORN; NONHUMAN; NUTRITION; PERINATAL PERIOD; PLACENTA WEIGHT; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; RAT; REPERFUSION INJURY; STRESS; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

ANIMALS; ANOXIA; BLOOD PRESSURE; BODY WEIGHT; DIET, HIGH-FAT; FEMALE; FETAL GROWTH RETARDATION; HEART; HEART RATE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84865117408     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00148.2012     Document Type: Article

References (47)

1. Ananth CV, Vintzileos AM. Distinguishing pathological from constitutional small for gestational age births in population-based studies. Early Hum Dev 85: 653-658, 2009.
2. Aziz W, Schlindwein FS, Wailoo M, Biala T, Rocha FC. Heart rate variability analysis of normal and growth restricted children. Clin Auton Res 22: 91-97, 2011.
3. Barker DJ. In utero programming of cardiovascular disease. Theriogenology 53: 555-574, 2000.
4. Barr RL, Lopaschuk GD. Direct measurement of energy metabolism in the isolated working rat heart. J Pharmacol Toxicol Methods 38: 11-17, 1997.
5. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506, 2006.
6. Beilin LJ. Lifestyle and hypertension-an overview. Clin Exp Hypertens 21: 749-762, 1999.
7. Bertram CE, Hanson MA. Animal models and programming of the metabolic syndrome. Br Med Bull 60: 103-121, 2001.
8. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15: 798-808, 2007.
9. Chen YR, Yi FF, Li XY, Wang CY, Chen L, Yang XC, Su PX, Cai J. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther 22: 479-485, 2008.
10. de Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesis. Aust NZ J Obstet Gynaecol 46: 4-14, 2006.
11. Deng JY, Hsieh PS, Huang JP, Lu LS, Hung LM. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and-independent pathways. Diabetes 57: 1814-1823, 2008.
12. Dittoe N, Stultz D, Schwartz BP, Hahn HS. Quantitative left ventricular systolic function: from chamber to myocardium. Crit Care Med 35: S330-S339, 2007.
13. Dolinsky VW, Chan AY, Robillard Frayne I, Light PE, Des Rosiers C, Dyck JR. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation 119: 1643-1652, 2009.
14. Dolinsky VW, Dyck JR. Calorie restriction and resveratrol in cardiovascular health and disease. Biochim Biophys Acta 1812: 1477-1489, 2011.
15. Dolinsky VW, Rueda-Clausen CF, Morton JS, Davidge ST, Dyck JR. Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 60: 2274-2284, 2011.
16. Goh SS, Woodman OL, Pepe S, Cao AH, Qin C, Ritchie RH. The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid Redox Signal 9: 101-113, 2007.
17. Huang JP, Huang SS, Deng JY, Chang CC, Day YJ, Hung LM. Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. Free Radic Biol Med 49: 1710-1721, 2010.
18. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23: 434-439, 2003.
19. Koonen DP, Sung MM, Kao CK, Dolinsky VW, Koves TR, Ilkayeva O, Jacobs RL, Vance DE, Light PE, Muoio DM, Febbraio M, Dyck JR. Alterations in skeletal muscle fatty acid handling predisposes middleaged mice to diet-induced insulin resistance. Diabetes 59: 1366-1375, 2010.
20. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122, 2006.
21. Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res 93: e33-e37, 2003.
22. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66: 546-553, 1990.
23. Marsal K. Intrauterine growth restriction. Curr Opin Obstet Gynecol 14: 127-135, 2002.
24. Meyer K, Lubo Z. Fetal programming of cardiac function and disease. Reprod Sci 14: 209-216, 2007.
25. Morton JS, Rueda-Clausen CF, Davidge ST. Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia. J Appl Physiol 110: 1073-1082, 2011.
26. Morton JS, Rueda-Clausen CF, Davidge ST. Mechanisms of endothelium-dependent vasodilation in male and female, young and aged off-spring born growth restricted. Am J Physiol Regul Integr Comp Physiol 298: R930-R938, 2010.
27. Nuyt AM, Alexander BT. Developmental programming and hypertension. Curr Opin Nephrol Hypertens 18: 144-152, 2009.
28. Peleg D, Kennedy CM, Hunter SK. Intrauterine growth restriction: identification and management. Am Fam Physician 58: 453-460, 466-457, 1998.
29. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D, Maulik N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med 12: 2350-2361, 2008.
30. Rivera L, Moron R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77: 1053-1063, 2009.
31. Rudyk O, Makra P, Jansen E, Shattock MJ, Poston L, Taylor PD. Increased cardiovascular reactivity to acute stress and salt-loading in adult male offspring of fat fed non-obese rats. PLos One 6: e25250, 2011.
32. Rueda-Clausen CF, Dolinsky VW, Morton JS, Proctor SD, Dyck JR, Davidge ST. Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes 60: 507-516, 2011.
33. Rueda-Clausen CF, Morton JS, Davidge ST. Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res 81: 713-722, 2009.
34. Rueda-Clausen CF, Morton JS, Lopaschuk GD, Davidge ST. Longterm effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion. Cardiovasc Res 90: 285-294, 2011.
35. Salvadori M, Sontrop JM, Garg AX, Truong J, Suri RS, Mahmud FH, Macnab JJ, Clark WF. Elevated blood pressure in relation to overweight and obesity among children in a rural Canadian community. Pediatrics 122: e821-e827, 2008.
36. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 26: 831-843, 2008.
37. Schwartz J, Thornburg KL. The influence of various physiological challenges on permanent changes to the cardiovascular system. Arch Physiol Biochem 111: 3-7, 2003.
38. Scifres CM, Nelson DM. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 587: 3453-3458, 2009.
39. Stocker CJ, Arch JR, Cawthorne MA. Fetal origins of insulin resistance and obesity. Proc Nutr Soc 64: 143-151, 2005.
40. Thornburg KL. Hypoxia and cardiac programming. J Soc Gynecol Investig 10: 251, 2003.
41. Ussher JR, Koves TR, Jaswal JS, Zhang L, Ilkayeva O, Dyck JR, Muoio DM, Lopaschuk GD. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes 58: 1766-1775, 2009.
42. Vuguin PM. Animal models for small for gestational age and fetal programming of adult disease. Horm Res 68: 113-123, 2007.
43. Williams SJ, Campbell ME, McMillen IC, Davidge ST. Differential effects of maternal hypoxia or nutrient restriction on carotid and femoral vascular function in neonatal rats. Am J Physiol Regul Integr Comp Physiol 288: R360-R367, 2005.
44. Williams SJ, Hemmings DG, Mitchell JM, McMillen IC, Davidge ST. Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring. J Physiol 565: 125-135, 2005.
45. Xu Y, Clanachan AS, BIJ. Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase cepsilon during cardioprotection induced by angiotensin II type 2 receptor blockade. Hypertension 36: 506-510, 2000.
46. Xu Y, Kumar D, Dyck JR, Ford WR, Clanachan AS, Lopaschuk GD, Jugdutt BI. AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol Heart Circ Physiol 282: H1206-H1215, 2002.
47. Xu Y, Williams SJ, O'Brien D, Davidge ST. Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J 20: 1251-1253, 2006.